Cargando…

EORTC Early Clinical Studies Group early phase II trial of S-1 in patients with advanced or metastatic colorectal cancer

Cancer of the colon and rectum is one of the most frequent malignancies both in the US and Europe. Standard palliative therapy is based on 5-fluorouracil/folinic acid combinations, with or without oxaliplatin or irinotecan, given intravenously. Oral medication has the advantage of greater patient co...

Descripción completa

Detalles Bibliográficos
Autores principales:	Van den Brande, J, Schöffski, P, Schellens, J H M, Roth, A D, Duffaud, F, Weigang-Köhler, K, Reinke, F, Wanders, J, de Boer, R F, Vermorken, J B, Fumoleau, P
Formato:	Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2003
Materias:	Clinical
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2376342/ https://www.ncbi.nlm.nih.gov/pubmed/12659110 http://dx.doi.org/10.1038/sj.bjc.6600781

Ejemplares similares

Phase II study of rhizoxin in squamous cell head and neck cancer. The EORTC Early Clinical Trials Group.
por: Verweij, J., et al.
Publicado: (1996)

Docetaxel (Taxotere) is active in non-small-cell lung cancer: a phase II trial of the EORTC Early Clinical Trials Group (ECTG)
por: Cerny, T., et al.
Publicado: (1994)

Docetaxel (Taxotere) in advanced gastric cancer: results of a phase II clinical trial. EORTC Early Clinical Trials Group.
por: Sulkes, A., et al.
Publicado: (1994)

Docetaxel (Taxotere), a novel taxoid, in the treatment of advanced colorectal carcinoma: an EORTC Early Clinical Trials Group Study.
por: Sternberg, C. N., et al.
Publicado: (1994)

Phase II clinical trials with rhizoxin in breast cancer and melanoma. The EORTC Early Clinical Trials Group.
por: Hanauske, A. R., et al.
Publicado: (1996)

Cisplatin, vincristine and ifosphamide combination chemotherapy of metastatic seminoma: results of EORTC trial 30874. EORTC GU Group.
por: Fosså, S. D., et al.
Publicado: (1995)

iCREATE: imaging features of primary and metastatic alveolar soft part sarcoma from the EORTC CREATE study
por: Mcaddy, Naami Charlotte, et al.
Publicado: (2020)

Single agent activity of rhizoxin in non-small-cell lung cancer: a phase II trial of the EORTC Early Clinical Trials Group.
por: Kaplan, S., et al.
Publicado: (1996)

Multicentre phase II pharmacological evaluation of rhizoxin. Eortc early clinical studies (ECSG)/pharmacology and molecular mechanisms (PAMM) groups.
por: McLeod, H. L., et al.
Publicado: (1996)

Results of screening in early and advanced thoracic malignancies in the EORTC pan-European SPECTAlung platform
por: Morfouace, M., et al.
Publicado: (2022)

Methylene blue in the treatment and prevention of ifosfamide-induced encephalopathy: report of 12 cases and a review of the literature
por: Pelgrims, J, et al.
Publicado: (2000)

Surgical management of melanoma: an EORTC Melanoma Group survey
por: Testori, A, et al.
Publicado: (2013)

FDG PET/CT for prognostic stratification of patients with metastatic breast cancer treated with first line systemic therapy: Comparison of EORTC criteria and PERCIST
por: Depardon, Edouard, et al.
Publicado: (2018)

Early detection of treatment futility in patients with metastatic colorectal cancer
por: Rattner, Jodi I., et al.
Publicado: (2022)

Mitoxantrone in metastatic apudomas: a phase II study of the EORTC Gastro-Intestinal Cancer Cooperative Group.
por: Neijt, J. P., et al.
Publicado: (1995)

Sex‐dependent least toxic timing of irinotecan combined with chronomodulated chemotherapy for metastatic colorectal cancer: Randomized multicenter EORTC 05011 trial
por: Innominato, Pasquale F., et al.
Publicado: (2020)

Quantitative evidence for early metastatic seeding in colorectal cancer
por: Hu, Zheng, et al.
Publicado: (2019)

Quality assurance of radiotherapy in the ongoing EORTC 1420 “Best of” trial for early stage oropharyngeal, supraglottic and hypopharyngeal carcinoma: results of the benchmark case procedure
por: Stelmes, J-J, et al.
Publicado: (2021)

A phase I study of bendamustine hydrochloride administered day 1+2 every 3 weeks in patients with solid tumours
por: Rasschaert, M, et al.
Publicado: (2007)

Development of a questionnaire (EORTC module) to measure quality of life in patients with cholangiocarcinoma and gallbladder cancer, the EORTC QLQ-BIL21
por: Friend, E, et al.
Publicado: (2011)

A multicentre phase II study of docetaxel 75 mg m-2 as first-line chemotherapy for patients with advanced breast cancer: report of the Clinical Screening Group of the EORTC. European Organization for Research and Treatment of Cancer.
por: Dieras, V., et al.
Publicado: (1996)

Safety and efficacy of Pazopanib in advanced soft tissue sarcoma: PALETTE (EORTC 62072) subgroup analyses
por: Cesne, Axel Le, et al.
Publicado: (2019)

Melanoma risk and residence in sunny areas. EORTC Melanoma Co-operative Group. European Organization for Research and Treatment of Cancer.
por: Autier, P., et al.
Publicado: (1997)

Strategies to promote translational research within the European Organisation for Research and Treatment of Cancer (EORTC) Head and Neck Cancer Group: a report from the Translational Research Subcommittee
por: Psyrri, A., et al.
Publicado: (2010)

Early identification of treatment benefit by methylated circulating tumor DNA in metastatic colorectal cancer
por: Thomsen, Caroline B., et al.
Publicado: (2020)

Validation of the chinese version of the EORTC QLQ-CR29 in patients with colorectal cancer
por: Lin, Jin-Bo, et al.
Publicado: (2017)

Evaluation of the performance of algorithms mapping EORTC QLQ-C30 onto the EQ-5D index in a metastatic colorectal cancer cost-effectiveness model
por: Franken, Mira D., et al.
Publicado: (2020)

The EORTC QLQ-CR29 quality of life questionnaire for colorectal cancer: validation of the Dutch version
por: Stiggelbout, A. M., et al.
Publicado: (2015)

A meta-analysis of two randomised trials of early chemotherapy in asymptomatic metastatic colorectal cancer
por: Ackland, S P, et al.
Publicado: (2005)

Translation and validation of the EORTC brain cancer module (EORTC QLQ-BN20) for use in Iran
por: Khoshnevisan, Alireza, et al.
Publicado: (2012)

Development of an item bank for the EORTC Role Functioning Computer Adaptive Test (EORTC RF-CAT)
por: Gamper, Eva-Maria, et al.
Publicado: (2016)

Interpreting Within-Patient Changes on the EORTC QLQ-C30 and EORTC QLQ-LC13
por: Coon, Cheryl D., et al.
Publicado: (2022)

Early results of quality of life for curatively treated rectal cancers in Chinese patients with EORTC QLQ-CR29
por: Peng, Junjie, et al.
Publicado: (2011)

The EORTC QLU-C10D: The Canadian Valuation Study and Algorithm to Derive Cancer-Specific Utilities From the EORTC QLQ-C30
por: McTaggart-Cowan, Helen, et al.
Publicado: (2019)

Assessment of bone response to systemic therapy in an EORTC trial: preliminary experience with the use of collagen cross-link excretion
por: Vinholes, J, et al.
Publicado: (1999)

Burden of early, advanced and metastatic breast cancer in The Netherlands
por: Vondeling, G. T., et al.
Publicado: (2018)

Efficacy and safety of chronomodulated irinotecan, oxaliplatin, 5‐fluorouracil and leucovorin combination as first‐ or second‐line treatment against metastatic colorectal cancer: Results from the International EORTC 05011 Trial
por: Innominato, Pasquale F., et al.
Publicado: (2020)

Assessing measurement invariance in the EORTC QLQ-C30
por: van Roij, Janneke, et al.
Publicado: (2021)

Histopathological and Molecular Profiling of Clear Cell Sarcoma and Correlation with Response to Crizotinib: An Exploratory Study Related to EORTC 90101 “CREATE” Trial
por: Lee, Che-Jui, et al.
Publicado: (2021)

Reference values of EORTC QLQ-C30, EORTC QLQ-BR23, and EQ-5D-5L for women with non-metastatic breast cancer at diagnosis and 2 years after
por: Miret, Carme, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_ur9acgj2eueboap8ioifpjem4h